查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828198

2025年外泌體診斷與治療全球市場報告

Exosome Diagnostic And Therapeutic Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，外泌體診斷和治療市場呈指數級成長，從2024年的4.7億美元成長到2025年的6億美元，複合年成長率為29.3%。預測期內的成長歸因於生物學研究的進步、精準醫療的興起、生物醫學影像、癌症研究和腫瘤學的創新以及醫療保健產業的投資。

預計未來幾年外泌體診斷和治療市場規模將呈指數級成長，到2029年將達到16.2億美元，年複合成長率（CAGR）為28.0%。預測期內的成長可歸因於不斷擴展的臨床應用、與數位健康技術的整合、有利的法規環境、基因編輯和RNA療法，以及免疫腫瘤學日益重要的作用。預測期內的主要趨勢包括基於外泌體的藥物發現、仿生外泌體工程、外泌體產品的商業化、外泌體負載的治療性藥物以及用於癌症篩檢的液態切片。

外泌體診斷與治療涉及利用外泌體（細胞產生的細胞外小顆粒）進行診斷和治療。外泌體在治療上被用作遞送標靶藥物的手段，尤其是在再生醫學領域。

外泌體診斷和治療市場的關鍵產品是儀器、軟體、試劑和套件。儀器是指用於準確、精確地執行活動和實驗的設備。這些產品在診斷和治療領域有著廣泛的應用，並提供給各種最終用戶，包括學術和研究機構、製藥和生物技術公司、醫院和診所。

2025年春季，美國關稅突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰進一步加劇了形勢，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供外泌體診斷和治療市場統計數據，包括全球市場規模、區域佔有率、外泌體診斷和治療市場佔有率的競爭對手、詳細的外泌體診斷和治療細分市場、市場趨勢和商業機會，以及您在外泌體診斷和治療行業取得成功所需的數據。這份外泌體診斷和治療市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供全面觀點所需的一切。

我們對該市場未來五年28.0%的成長率預測與先前的預測一致。下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自瑞士和韓國等主要地區的超速離心管和奈米顆粒追蹤分析儀徵收關稅直接影響美國，從而可能減緩精準醫療的進展，並增加新型生物標記研究的成本。這種影響可能會透過互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，更廣泛地顯現出來。

外泌體診斷和治療市場的預期成長主要受到慢性病盛行率上升的強烈推動。慢性病持續超過三個月，且往往會隨著時間的推移而惡化，是全球面臨的重大健康問題。外泌體既可用於診斷，也可用於治療，已成為癌症領域極具前景的生物標記物，能夠實現更靈敏的疾病監測，並促進個人化醫療的普及。根據美國國家生物技術資訊中心 (NCBI) 於 2023 年 1 月發布的預測，到 2050 年，全球慢性病患者人數將達到 1.4266 億。這項統計數據凸顯了慢性病盛行率上昇在推動外泌體診斷和治療市場發展的關鍵作用。

老年人口的成長進一步加速了外泌體診斷和治療市場的成長軌跡。 「老年人口」指的是65歲及以上的人。由於外泌體為診斷和治療與老齡化相關的疾病提供了寶貴的工具，因此人口結構的擴張極大地促進了對外泌體診斷和治療的需求。根據世界衛生組織（WHO）於2022年10月發布的報告，人口結構正在發生重大變化，預計到2030年，全球整體六分之一的人口將達到60歲或以上。到2050年，預計全球將有21億人達到60歲或以上。這項人口結構變化證實，老年人口的成長將對外泌體診斷和治療市場的成長產生重大影響。

主要企業正在積極開發創新產品，例如樣品純化系統，以擴大基本客群、增加銷售並推動收益成長。樣品純化系統包含一系列旨在從各種樣品類型（包括 DNA、RNA、蛋白質和其他生物分子）中去除雜質和污染物的製程和技術。例如，2023 年 2 月，美國著名生物技術公司 Biological Dynamics 推出了 ExoVita，這是一個專為早期疾病監測和多種應用而設計的外泌體分離平台。作為該平台的一部分，ExoVita 胰腺檢測證明了使用取得專利的ExoVerita 設備血液外泌體樣本識別特定外泌體蛋白指標並檢測 1 期和 2 期胰腺導管腺癌 (PDAC) 的能力。該公司正在透過 ExoLuminate 註冊試驗 (NCT05625529) 積極檢驗這些發現，該試驗正在招募高風險 PDAC 患者以評估該測試的臨床價值。

外泌體診斷和治療市場的主要企業正在採用策略聯盟方式來增強外泌體純化過程。策略夥伴關係是指公司利用彼此的優勢和資源，實現互利共贏的夥伴關係。一個值得注意的例子是美國著名生技公司 Cytiva 與另一家美國生技公司 RoosterBio 之間的合作。該合作於 2023 年 10 月宣布，旨在改進外泌體純化過程，這是目前阻礙有前景的基因療法和其他創新治療方法廣泛使用的瓶頸。透過結合兩家公司的優勢，此次合作旨在解決限制外泌體治療應用的關鍵挑戰，特別是作為基因療法和生技藥品的載體。預期結果是提高大規模外泌體製造能力。

2023年6月，英國生技公司Evox Therapeutics Ltd.以未揭露的金額收購了Codiak Biosciences的engEx-AAV技術平台。此次收購旨在利用engEx-AAV技術改進外泌體介導的遞送系統，並加速創新基因療法和基因組編輯技術的進步。這項策略決策旨在增強Evox Therapeutics在有效基因藥物開發方面的能力。 Kodiak Biosciences是一家專注於發現基於外泌體的療法的美國生物製藥公司。

外泌體診斷與治療市場的主要企業包括 Thermo Fisher Scientific Inc.、Lonza Group AG、Bio-Techne Corp.、Miltenyi Biotec GmBH、Malvern Instruments Inc.、BioVision Inc.、System Biosciences LLC、Evox Therapeutics Ltd.、ExCoBio Inc.、BioCatSombH、Nnos. Inc.、Aethlon Medical Inc.、Codiak BioSciences Inc.、NX Pharmagen Inc.、Exiqon A/S、Aegle Therapeutic Corporation、AMS Biotechnology Ltd.、Cell Guidance Systems、Ciloa、Sienna Diagnostics、Sistemic Inc.、Theoria Science 和 Mantra Bio Inc.

2024年外泌體診斷與治療市場最大的地區是北美。預計亞太地區將成為預測期內成長最快的地區。外泌體診斷和治療市場報告涵蓋以下地區：亞太地區、西歐、東歐、北美、南美、中東和非洲。

外泌體診斷和治療市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、義大利、西班牙和加拿大。

外泌體診斷和治療市場由提供基因組定序、EXOME定序、重定序和標靶定序等服務的營業單位所獲得的收益所構成。市場價值包括服務供應商銷售的或包含在其服務產品中的任何相關產品的價值。外泌體診斷和治療市場還包括用於提供外泌體藥物輸送服務的外泌體檢測試劑盒、外泌體流式細胞技術套件和蛋白質生物標記檢測套件的銷售。該市場的價值是指“出廠價”，即產品製造商或創造者銷售的產品價值，無論是銷售給其他營業單位（包括下游製造商、經銷商、分銷商和零售商）或直接銷售給最終客戶。該市場中的產品價值還包括產品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球外泌體診斷與治療：PESTEL分析（政治、社會、技術、環境、法律、促進因素與限制因素）
  • 最終用途產業分析
  • 全球外泌體診斷與治療市場：成長率分析
  • 全球外泌體診斷與治療市場表現：規模與成長，2019-2024
  • 全球外泌體診斷與治療市場預測：規模與成長，2024-2029年，2034年
  • 全球外泌體診斷與治療：總目標市場（TAM）

第6章 市場細分

  • 全球外泌體診斷與治療市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 裝置
  • 軟體
  • 試劑和套件
  • 全球外泌體診斷與治療市場：按應用、績效與預測，2019-2024 年、2024-2029 年、2034 年
  • 診斷
  • 治療
  • 全球外泌體診斷與治療市場：依最終使用者、績效與預測，2019-2024 年、2024-2029 年、2034 年
  • 學術研究機構
  • 製藥和生物技術公司
  • 醫院和診所
  • 其他最終用戶
  • 全球外泌體診斷與治療市場：按設備類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 外泌體分離系統
  • 特性分析設備
  • 分析器
  • 全球外泌體診斷與治療市場：按軟體類型、效能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 數據分析軟體
  • 外泌體分析軟體
  • 實驗室管理軟體
  • 全球外泌體診斷與治療市場：按試劑和套件（按類型）細分、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 隔離套件
  • 表徵試劑
  • 檢測試劑套件

第7章 區域和國家分析

  • 全球外泌體診斷與治療市場：按地區、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 全球外泌體診斷和治療市場：按國家/地區、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 外泌體診斷與治療市場：競爭格局
  • 外泌體診斷與治療市場：公司簡介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • Bio-Techne Corp. Overview, Products and Services, Strategy and Financial Analysis
    • Miltenyi Biotec GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Malvern Instruments Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • BioVision Inc.
  • System Biosciences LLC
  • Evox Therapeutics Ltd.
  • ExCoBio Inc.
  • BioCat GmbH
  • NanoSomix Inc.
  • Exosome Diagnostics Inc.
  • Capricor Therapeutics Inc.
  • Aethlon Medical Inc.
  • Codiak BioSciences Inc.
  • NX Pharmagen Inc.
  • Exiqon A/S
  • Aegle Therapeutics Corporation
  • AMS Biotechnology Ltd.
  • Cell Guidance Systems

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年外泌體診斷與治療市場：提供新機會的國家
  • 2029年外泌體診斷與治療市場：細分領域帶來新機會
  • 外泌體診斷與治療市場2029年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r24910u

Exosome diagnostics and therapeutics involve utilizing exosomes-small extracellular particles produced by cells-for both diagnostic and therapeutic purposes. Exosomes are employed in therapeutic applications as a means of delivering targeted medications, particularly within the field of regenerative medicine.

The primary products within the exosome diagnostic and therapeutic market comprise instruments, software, reagents, and kits. Instruments refer to equipment utilized for precise and accurate execution of activities or experiments. These products find diverse applications in diagnostics and therapeutics and cater to various end-users, including academic and research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The exosome diagnostic and therapeutic market research report is one of a series of new reports from The Business Research Company that provides exosome diagnostic and therapeutic market statistics, including exosome diagnostic and therapeutic industry global market size, regional shares, competitors with an exosome diagnostic and therapeutic market share, detailed exosome diagnostic and therapeutic market segments, market trends and opportunities, and any further data you may need to thrive in the exosome diagnostic and therapeutic industry. This exosome diagnostic and therapeutic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The exosome diagnostic and therapeutic market size has grown exponentially in recent years. It will grow from $0.47 billion in 2024 to $0.6 billion in 2025 at a compound annual growth rate (CAGR) of 29.3%. The growth in the historic period can be attributed to biological research advancements, the emergence of precision medicine, biomedical imaging innovations, cancer research and oncology, and healthcare industry investments.

The exosome diagnostic and therapeutic market size is expected to see exponential growth in the next few years. It will grow to $1.62 billion in 2029 at a compound annual growth rate (CAGR) of 28.0%. The growth in the forecast period can be attributed to growing clinical applications, integration with digital health technologies, supportive regulatory environment, gene editing and RNA therapeutics, and expanded role in immuno-oncology. Major trends in the forecast period include exosome-based drug discovery, biomimetic exosome engineering, commercialization of exosome products, exosome-loaded therapeutic cargo, and liquid biopsy for cancer screening.

The forecast of 28.0% growth over the next five years remains unchanged from the previous projection for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on ultracentrifugation tubes and nanoparticle tracking analyzers, sourced from key regions such as Switzerland and South Korea, which could lead to slowed advancements in precision medicine and higher costs for novel biomarker research.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated growth of the exosome diagnostic and therapeutic market is strongly driven by the increasing prevalence of chronic diseases. Chronic illnesses, lasting three months or more and prone to deterioration over time, are a significant health concern globally. Exosomes, utilized in both diagnostic and therapeutic capacities, emerge as promising biomarkers in cancer, enabling more sensitive disease monitoring and facilitating the accessibility of personalized medicine. In a projection from January 2023, the National Center for Biotechnology Information (NCBI) indicates a forecasted global count of 142.66 million individuals with chronic diseases by 2050. This statistic underscores the pivotal role played by the rising prevalence of chronic diseases in propelling the exosome diagnostics and therapeutics market.

The upward trajectory of the exosome diagnostic and therapeutic market is further fueled by the increasing size of the geriatric population. The term 'geriatric population' refers to individuals aged 65 years and older, often in the later stages of life. This demographic expansion contributes significantly to the demand for exosome diagnostics and therapeutics, as exosomes serve as valuable tools for diagnosing and addressing age-related conditions. Notably, a report from the World Health Organization (WHO) in October 2022 indicates a profound demographic shift, with one in six individuals projected to be 60 or older by 2030 globally. By 2050, an estimated 2.1 billion people worldwide will be 60 years old or older. This demographic shift underscores the substantial impact of the rising geriatric population on driving the growth of the exosome diagnostic and therapeutic market.

Major companies are actively engaged in developing innovative products, such as sample purification systems, to expand their customer base, boost sales, and drive revenue growth. A sample purification system encompasses a suite of processes and technologies designed to eliminate impurities and contaminants from various sample types, including DNA, RNA, proteins, and other biomolecules. As an illustration, in February 2023, Biological Dynamics Inc., a prominent US-based biotechnology company, introduced ExoVerita-an exosome-isolation platform designed for early disease surveillance and diverse applications. The ExoVita Pancreas assay, part of this platform, identifies specific exosomal protein indicators and has demonstrated the ability to detect Stage 1 and Stage 2 pancreatic ductal adenocarcinoma (PDAC) using blood-based exosome samples enriched on the patented ExoVerita apparatus. The company is actively validating these findings through the ExoLuminate registry trial (NCT05625529), recruiting high-risk PDAC patients to assess the clinical value of the test.

Major players in the exosome diagnostic and therapeutic market are adopting a strategic partnership approach to enhance the exosome purification process. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits and success. A noteworthy example is the collaboration between Cytiva, a prominent US-based biotechnology company, and RoosterBio Inc., also a US-based biotechnology company. Announced in October 2023, this partnership aims to improve the exosome purification process, a current bottleneck hindering the widespread adoption of promising gene therapies and other innovative modalities. By combining the strengths of both entities, the collaboration seeks to address a significant challenge limiting the use of exosomes in therapeutic applications, particularly as carriers for gene therapies and biologics. The envisioned outcome is the advancement of large-scale manufacturing capabilities for exosomes.

In June 2023, Evox Therapeutics Ltd., a biotechnology company based in the UK, acquired the engEx-AAV technology platform from Codiak Biosciences for an undisclosed sum. The purpose of this acquisition is to utilize the engEx-AAV technology to improve exosome-mediated delivery systems, facilitating the advancement of innovative gene therapies and genome editors. This strategic decision aims to bolster Evox Therapeutics' capabilities in developing effective genetic medicines. Codiak Biosciences is a biopharmaceutical company located in the US that focuses on creating exosome-based therapeutics.

Major companies operating in the exosome diagnostic and therapeutic market include Thermo Fisher Scientific Inc., Lonza Group AG, Bio-Techne Corp., Miltenyi Biotec GmBH, Malvern Instruments Inc., BioVision Inc., System Biosciences LLC, Evox Therapeutics Ltd., ExCoBio Inc., BioCat GmbH, NanoSomix Inc., Exosome Diagnostics Inc., Capricor Therapeutic Inc., Aethlon Medical Inc., Codiak BioSciences Inc., NX Pharmagen Inc., Exiqon A/S, Aegle Therapeutic Corporation, AMS Biotechnology Ltd., Cell Guidance Systems, Ciloa, Sienna Diagnostics, Sistemic Inc., Theoria Science, Mantra Bio Inc.

North America was the largest region in the exosome diagnostic and therapeutic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exosome diagnostic and therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the exosome diagnostic and therapeutic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The exosome diagnostic and therapeutic market consists of revenues earned by entities by providing services such as genomic sequencing, exome sequencing, resequencing, and targeted sequencing. The market value includes the value of related goods sold by the service provider or included within the service offering. The exosome diagnostic and therapeutic market also includes sales of exosome-based assays, exosome flow cytometry kits, and protein biomarker detection kits, which are used in providing exosome-based drug delivery services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Exosome Diagnostic And Therapeutic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on exosome diagnostic and therapeutic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for exosome diagnostic and therapeutic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The exosome diagnostic and therapeutic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Instruments; Software; Reagents And Kits
  • 2) By Application: Diagnostics; Therapeutic
  • 3) By End User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospitals And Clinics; Other End Users
  • Subsegments:
  • 1) By Instruments: Exosome Isolation Systems; Characterization Instruments; Analysis Devices
  • 2) By Software: Data Analysis Software; Exosome Profiling Software; Laboratory Management Software
  • 3) By Reagents And KITS: Isolation KITS; Characterization Reagents; Assay KITS
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Lonza Group AG; Bio-Techne Corp.; Miltenyi Biotec GmBH; Malvern Instruments Inc.; BioVision Inc.; System Biosciences LLC; Evox Therapeutics Ltd.; ExCoBio Inc.; BioCat GmbH; NanoSomix Inc.; Exosome Diagnostics Inc.; Capricor Therapeutic Inc.; Aethlon Medical Inc.; Codiak BioSciences Inc.; NX Pharmagen Inc.; Exiqon A/S; Aegle Therapeutic Corporation; AMS Biotechnology Ltd.; Cell Guidance Systems; Ciloa; Sienna Diagnostics; Sistemic Inc.; Theoria Science; Mantra Bio Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Exosome Diagnostic And Therapeutic Market Characteristics

3. Exosome Diagnostic And Therapeutic Market Trends And Strategies

4. Exosome Diagnostic And Therapeutic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Exosome Diagnostic And Therapeutic Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Exosome Diagnostic And Therapeutic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Exosome Diagnostic And Therapeutic Market Growth Rate Analysis
  • 5.4. Global Exosome Diagnostic And Therapeutic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Exosome Diagnostic And Therapeutic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Exosome Diagnostic And Therapeutic Total Addressable Market (TAM)

6. Exosome Diagnostic And Therapeutic Market Segmentation

  • 6.1. Global Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Software
  • Reagents And Kits
  • 6.2. Global Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostics
  • Therapeutic
  • 6.3. Global Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic And Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Hospitals And Clinics
  • Other End Users
  • 6.4. Global Exosome Diagnostic And Therapeutic Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Exosome Isolation Systems
  • Characterization Instruments
  • Analysis Devices
  • 6.5. Global Exosome Diagnostic And Therapeutic Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Analysis Software
  • Exosome Profiling Software
  • Laboratory Management Software
  • 6.6. Global Exosome Diagnostic And Therapeutic Market, Sub-Segmentation Of Reagents And KITS, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Isolation KITS
  • Characterization Reagents
  • Assay KITS

7. Exosome Diagnostic And Therapeutic Market Regional And Country Analysis

  • 7.1. Global Exosome Diagnostic And Therapeutic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Exosome Diagnostic And Therapeutic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Exosome Diagnostic And Therapeutic Market

  • 8.1. Asia-Pacific Exosome Diagnostic And Therapeutic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Exosome Diagnostic And Therapeutic Market

  • 9.1. China Exosome Diagnostic And Therapeutic Market Overview
  • 9.2. China Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Exosome Diagnostic And Therapeutic Market

  • 10.1. India Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Exosome Diagnostic And Therapeutic Market

  • 11.1. Japan Exosome Diagnostic And Therapeutic Market Overview
  • 11.2. Japan Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Exosome Diagnostic And Therapeutic Market

  • 12.1. Australia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Exosome Diagnostic And Therapeutic Market

  • 13.1. Indonesia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Exosome Diagnostic And Therapeutic Market

  • 14.1. South Korea Exosome Diagnostic And Therapeutic Market Overview
  • 14.2. South Korea Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Exosome Diagnostic And Therapeutic Market

  • 15.1. Western Europe Exosome Diagnostic And Therapeutic Market Overview
  • 15.2. Western Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Exosome Diagnostic And Therapeutic Market

  • 16.1. UK Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Exosome Diagnostic And Therapeutic Market

  • 17.1. Germany Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Exosome Diagnostic And Therapeutic Market

  • 18.1. France Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Exosome Diagnostic And Therapeutic Market

  • 19.1. Italy Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Exosome Diagnostic And Therapeutic Market

  • 20.1. Spain Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Exosome Diagnostic And Therapeutic Market

  • 21.1. Eastern Europe Exosome Diagnostic And Therapeutic Market Overview
  • 21.2. Eastern Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Exosome Diagnostic And Therapeutic Market

  • 22.1. Russia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Exosome Diagnostic And Therapeutic Market

  • 23.1. North America Exosome Diagnostic And Therapeutic Market Overview
  • 23.2. North America Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Exosome Diagnostic And Therapeutic Market

  • 24.1. USA Exosome Diagnostic And Therapeutic Market Overview
  • 24.2. USA Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Exosome Diagnostic And Therapeutic Market

  • 25.1. Canada Exosome Diagnostic And Therapeutic Market Overview
  • 25.2. Canada Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Exosome Diagnostic And Therapeutic Market

  • 26.1. South America Exosome Diagnostic And Therapeutic Market Overview
  • 26.2. South America Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Exosome Diagnostic And Therapeutic Market

  • 27.1. Brazil Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Exosome Diagnostic And Therapeutic Market

  • 28.1. Middle East Exosome Diagnostic And Therapeutic Market Overview
  • 28.2. Middle East Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Exosome Diagnostic And Therapeutic Market

  • 29.1. Africa Exosome Diagnostic And Therapeutic Market Overview
  • 29.2. Africa Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Exosome Diagnostic And Therapeutic Market Competitive Landscape And Company Profiles

  • 30.1. Exosome Diagnostic And Therapeutic Market Competitive Landscape
  • 30.2. Exosome Diagnostic And Therapeutic Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bio-Techne Corp. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Miltenyi Biotec GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Malvern Instruments Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Exosome Diagnostic And Therapeutic Market Other Major And Innovative Companies

  • 31.1. BioVision Inc.
  • 31.2. System Biosciences LLC
  • 31.3. Evox Therapeutics Ltd.
  • 31.4. ExCoBio Inc.
  • 31.5. BioCat GmbH
  • 31.6. NanoSomix Inc.
  • 31.7. Exosome Diagnostics Inc.
  • 31.8. Capricor Therapeutics Inc.
  • 31.9. Aethlon Medical Inc.
  • 31.10. Codiak BioSciences Inc.
  • 31.11. NX Pharmagen Inc.
  • 31.12. Exiqon A/S
  • 31.13. Aegle Therapeutics Corporation
  • 31.14. AMS Biotechnology Ltd.
  • 31.15. Cell Guidance Systems

32. Global Exosome Diagnostic And Therapeutic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Exosome Diagnostic And Therapeutic Market

34. Recent Developments In The Exosome Diagnostic And Therapeutic Market

35. Exosome Diagnostic And Therapeutic Market High Potential Countries, Segments and Strategies

  • 35.1 Exosome Diagnostic And Therapeutic Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Exosome Diagnostic And Therapeutic Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Exosome Diagnostic And Therapeutic Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer